These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16022854)

  • 1. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
    Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
    Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
    Hall P; Bahamondes L; Diaz J; Petta C
    Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
    Hassan EO; el-Nahal N; el-Hussein M
    Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
    Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
    Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclofem shoots into injectable market.
    Family Plan World; 1992; ():19. PubMed ID: 12290896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
    Cuong DT; My Huong NT
    Contraception; 1996 Sep; 54(3):169-79. PubMed ID: 8899259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
    Garza-Flores J; Moraks del Olmo A; Fuziwara JL; Figueroa JG; Alonso A; Monroy J; Perez M; Urbina-Fuentes M; Guevara SJ; Cedeno E; Barrios R; Ferman JJ; Medina LM; Velazquez E; Perez-Palacios G
    Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
    Hassan EO; el-Nahal N; el-Hussinie M
    Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.
    Simbar M; Tehrani FR; Hashemi Z; Zham H; Fraser IS
    J Fam Plann Reprod Health Care; 2007 Oct; 33(4):271-6. PubMed ID: 17925114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
    Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
    Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
    Bahamondes L; Lavín P; Ojeda G; Petta C; Diaz J; Maradiegue E; Monteiro I
    Contraception; 1997 May; 55(5):307-10. PubMed ID: 9220228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.